The application dimension of the Indeflator Devices market is segmented into four primary categories: Surgical, Diagnostic, Therapeutic and Research. Surgical devices, which facilitate controlled inflation and deflation during minimally invasive procedures, dominate the market, accounting for roughly 45 % of total revenue due to high procedure volumes and regulatory endorsement. Diagnostic applications, such as contrast‑enhanced imaging and pressure‑modulated ultrasound, contribute about 25 % of sales, driven by expanding imaging centers and the need for precise physiological measurements. The Therapeutic segment, encompassing wound‑care dressings and pressure‑relief systems, represents roughly 20 % of the market, reflecting growing chronic‑care populations. Finally, Research devices, used in laboratory and pre‑clinical studies, hold a 10 % share, supported by ongoing innovation in biomedical research. These proportions collectively shape the overall Indeflator Devices segmentation landscape and are illustrated in the accompanying pie chart.